| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 69,326 | 58,194 | 40,021 | 49,529 | | Cost of Revenue | 28,583 | 21,608 | 15,891 | 5,717 | | | Gross Profit | 40,743 | 36,586 | 24,130 | 43,812 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,178 | 22,418 | 14,023 | 30,090 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 6,403 | 6,238 | 6,551 | 6,008 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,669 | 7,930 | 3,556 | 7,714 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 462 | 375 | 449 | 1,749 | | Earnings Before Interest And Taxes | 12,131 | 8,406 | 3,904 | (3,735) | | Interest Expense | 4,114 | 3,988 | 3,788 | 3,668 | | Income Before Tax | 8,017 | 4,418 | 116 | (7,403) | | Income Tax Expense |
-
| (101) | 101 | 1,587 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (794) | 4,418 | 116 | 4,208 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,017 | 4,418 | 116 | 4,208 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,017 | $4,418 | $116 | $4,208 |
|
0.02% Nasdaq 
0.33%
Income Statement
